These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 31386864)
21. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease. Velmurugan D; Mythily U; Rao K Protein Pept Lett; 2014; 21(8):815-27. PubMed ID: 23855663 [TBL] [Abstract][Full Text] [Related]
22. In-silico identification and evaluation of plant flavonoids as dengue NS2B/NS3 protease inhibitors using molecular docking and simulation approach. Qamar MT; Ashfaq UA; Tusleem K; Mumtaz A; Tariq Q; Goheer A; Ahmed B Pak J Pharm Sci; 2017 Nov; 30(6):2119-2137. PubMed ID: 29175781 [TBL] [Abstract][Full Text] [Related]
23. Schisandrin A inhibits dengue viral replication via upregulating antiviral interferon responses through STAT signaling pathway. Yu JS; Wu YH; Tseng CK; Lin CK; Hsu YC; Chen YH; Lee JC Sci Rep; 2017 Mar; 7():45171. PubMed ID: 28338050 [TBL] [Abstract][Full Text] [Related]
24. Human Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P) regulates cytoplasmic lipid droplet abundance: A potential target for indirect-acting anti-dengue virus agents. Hyrina A; Meng F; McArthur SJ; Eivemark S; Nabi IR; Jean F PLoS One; 2017; 12(3):e0174483. PubMed ID: 28339489 [TBL] [Abstract][Full Text] [Related]
25. Dengue virus non-structural protein 3 inhibits mitochondrial respiration by impairing complex I function. Sousa BG; Mebus-Antunes NC; Fernandes-Siqueira LO; Caruso MB; Saraiva GN; Carvalho CF; Neves-Martins TC; Galina A; Zingali RB; Zeidler JD; Da Poian AT mSphere; 2024 Jul; 9(7):e0040624. PubMed ID: 38980068 [TBL] [Abstract][Full Text] [Related]
26. Ten years of dengue drug discovery: progress and prospects. Lim SP; Wang QY; Noble CG; Chen YL; Dong H; Zou B; Yokokawa F; Nilar S; Smith P; Beer D; Lescar J; Shi PY Antiviral Res; 2013 Nov; 100(2):500-19. PubMed ID: 24076358 [TBL] [Abstract][Full Text] [Related]
27. Identification of inhibitors of dengue viral replication using replicon cells expressing secretory luciferase. Kato F; Nio Y; Yagasaki K; Suzuki R; Hijikata M; Miura T; Miyazaki I; Tajima S; Lim CK; Saijo M; Takasaki T; Hishiki T Antiviral Res; 2019 Dec; 172():104643. PubMed ID: 31678478 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of protein kinase C promotes dengue virus replication. Noppakunmongkolchai W; Poyomtip T; Jittawuttipoka T; Luplertlop N; Sakuntabhai A; Chimnaronk S; Jirawatnotai S; Tohtong R Virol J; 2016 Mar; 13():35. PubMed ID: 26931565 [TBL] [Abstract][Full Text] [Related]
29. A peptide inhibitor derived from the conserved ectodomain region of DENV membrane (M) protein with activity against dengue virus infection. Panya A; Sawasdee N; Junking M; Srisawat C; Choowongkomon K; Yenchitsomanus PT Chem Biol Drug Des; 2015 Nov; 86(5):1093-104. PubMed ID: 25891143 [TBL] [Abstract][Full Text] [Related]
30. Dengue in the Dominican Republic: epidemiology for 2004. Cabrera-Batista B; Skewes-Ramm R; Fermin CD; Garry RF Microsc Res Tech; 2005 Nov; 68(3-4):250-4. PubMed ID: 16276520 [TBL] [Abstract][Full Text] [Related]
31. Lucidone suppresses dengue viral replication through the induction of heme oxygenase-1. Chen WC; Tseng CK; Lin CK; Wang SN; Wang WH; Hsu SH; Wu YH; Hung LC; Chen YH; Lee JC Virulence; 2018 Jan; 9(1):588-603. PubMed ID: 29338543 [TBL] [Abstract][Full Text] [Related]
32. A novel dengue virus inhibitor, BP13944, discovered by high-throughput screening with dengue virus replicon cells selects for resistance in the viral NS2B/NS3 protease. Yang CC; Hu HS; Wu RH; Wu SH; Lee SJ; Jiaang WT; Chern JH; Huang ZS; Wu HN; Chang CM; Yueh A Antimicrob Agents Chemother; 2014; 58(1):110-9. PubMed ID: 24145533 [TBL] [Abstract][Full Text] [Related]
33. Dengue Virus Inhibition of Autophagic Flux and Dependency of Viral Replication on Proteasomal Degradation of the Autophagy Receptor p62. Metz P; Chiramel A; Chatel-Chaix L; Alvisi G; Bankhead P; Mora-Rodriguez R; Long G; Hamacher-Brady A; Brady NR; Bartenschlager R J Virol; 2015 Aug; 89(15):8026-41. PubMed ID: 26018155 [TBL] [Abstract][Full Text] [Related]
34. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side. Lin KH; Ali A; Rusere L; Soumana DI; Kurt Yilmaz N; Schiffer CA J Virol; 2017 May; 91(10):. PubMed ID: 28298600 [TBL] [Abstract][Full Text] [Related]
35. Nuclear localization of dengue virus (DENV) 1-4 non-structural protein 5; protection against all 4 DENV serotypes by the inhibitor Ivermectin. Tay MY; Fraser JE; Chan WK; Moreland NJ; Rathore AP; Wang C; Vasudevan SG; Jans DA Antiviral Res; 2013 Sep; 99(3):301-6. PubMed ID: 23769930 [TBL] [Abstract][Full Text] [Related]